Celerite Slimming Capsules: Undeclared Drug Ingredient

January 13, 2011

Audience: Consumer

ISSUE: FDA laboratory analysis confirmed that Celerite Slimming Capsules contain sibutramine, a controlled substance that was withdrawn from the market in October 2010 for safety reasons. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. This product may also interact in life threatening ways with other medications a consumer may be taking.

BACKGROUND: Celerite Slimming Capsules, marketed as a dietary supplement for weight loss, is sold on various websites. Claims made for the product falsely state that it is "safe" and an "all-natural herbal weight loss remedy."

RECOMMENDATION: Consumers should stop using this product immediately and throw it away. Consumers who have experienced any negative side effects should consult a health care professional as soon as possible.


Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178


[01/12/2011 - Public Notification - FDA]
[01/12/2011 - Celerite Slimming Capsules Blister Pack Photo - FDA]
[01/12/2011 - Tainted Weight Loss Products - FDA]

View comments

Hide
(web4)